Chibroxin side effects by duration, gender and age - a phase IV clinical study of FDA data
Summary:
Side effects are reported by people who take Chibroxin. Common side effects include abdominal pain upper among females and angioneurotic oedema among males.
The phase IV clinical study is created by eHealthMe based on 13 reports from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
13 people who take Chibroxin and have side effects are studied.
What is Chibroxin?
Chibroxin has active ingredients of norfloxacin. eHealthMe is studying from 13 Chibroxin users for its effectiveness, alternative drugs and more.
Number of Chibroxin reports submitted per year:
Chibroxin side effects by time on the drug*:
< 1 month:
- Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
- Conjunctival oedema (conjunctival swelling)
- Erythema (redness of the skin)
1 - 6 months:
n/a
6 - 12 months:
n/a
1 - 2 years:
n/a
2 - 5 years:
n/a
5 - 10 years:
n/a
10+ years:
n/a
not specified:
- Angioneurotic oedema (swelling that occurs just beneath the surface of the skin or mucous membranes)
- Abdominal pain upper
- Corneal deposits
- Corneal epithelium defect (outer layer defect of cornea)
- Corneal erosion (failure of the cornea's outermost layer of epithelial cells to attach to the underlying)
Chibroxin side effects by gender *:
female:
- Abdominal pain upper
- Angioneurotic oedema (swelling that occurs just beneath the surface of the skin or mucous membranes)
- Conjunctival oedema (conjunctival swelling)
- Corneal epithelium defect (outer layer defect of cornea)
- Corneal erosion (failure of the cornea's outermost layer of epithelial cells to attach to the underlying)
male:
- Angioneurotic oedema (swelling that occurs just beneath the surface of the skin or mucous membranes)
- Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
- Corneal deposits
- Erythema (redness of the skin)
Chibroxin side effects by age (0-1 to 60+) *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
- Angioneurotic oedema (swelling that occurs just beneath the surface of the skin or mucous membranes)
30-39:
- Abdominal pain upper
40-49:
- Angioneurotic oedema (swelling that occurs just beneath the surface of the skin or mucous membranes)
50-59:
- Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
- Erythema (redness of the skin)
60+:
- Conjunctival oedema (conjunctival swelling)
- Corneal deposits
- Corneal epithelium defect (outer layer defect of cornea)
- Corneal erosion (failure of the cornea's outermost layer of epithelial cells to attach to the underlying)
* Approximation only. Some reports may have incomplete information.
Do you take Chibroxin?
Personalize this study to your gender and ageHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How the study uses the data?
The study is based on norfloxacin (the active ingredients of Chibroxin) and Chibroxin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered.
Related studies
Alternative drugs to, pros and cons of Chibroxin:
- Chibroxin (13 reports)
All Chibroxin side effects from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zWho is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Norvasc and Lithane drug interaction - 5 seconds ago
- Carvedilol and Bruxism - 7 seconds ago
- Taste - Impaired and drugs of ingredients of oats - 8 seconds ago
- Otezla and Acute Myeloid Leukaemia - 11 seconds ago
- Zanaflex and Pain - 17 seconds ago
- Hydroxychloroquine Sulfate and Bone Cyst - 24 seconds ago
- Aleve and Accuretic drug interaction - 24 seconds ago
- Csa and Fever - 37 seconds ago
- Benztropine Mesylate and Thrombocythaemia - 50 seconds ago
- Iclusig and Tumor Marker Increased - a minute ago